About Arcus Medical
Pioneering minimally invasive solutions to transform women’s health
Our Mission
Arcus Medical was founded on a simple yet powerful observation: 88% of women with pelvic organ prolapse are left untreated. While the medical community has focused on surgical solutions for the minority who can afford invasive procedures, millions of women suffer in silence.
We’re changing that paradigm. The Arcus TLT (Tissue Lifting & Tensioning) device represents a breakthrough in minimally invasive care — a 10-minute, office-based procedure that restores quality of life without the barriers of traditional surgery.
Our team brings together clinical expertise, scientific innovation, and strategic business acumen to deliver a solution that is effective, accessible, and immediately reimbursable. With the FDA’s removal of transvaginal mesh from the market, the timing has never been more critical.
We’re not just building a medical device — we’re building a movement to serve the underserved.
Leadership Team
Experienced leaders combining clinical expertise, scientific innovation, and business strategy
Hugo H. Davila, MD
Dr. Hugo H. Davila is a board-certified urologist with extensive experience in pelvic floor disorders and minimally invasive surgical techniques. His clinical expertise and innovative vision drive Arcus Medical's mission.
Raul Storey, MD
Dr. Raul Storey brings deep clinical expertise in oncology and a strategic perspective on medical device development. His experience informs Arcus's patient-first approach.
Chris Rowland
Chris Rowland provides strategic leadership with a proven track record in medical device commercialization and market development. His expertise drives Arcus's go-to-market strategy.
Victor Solano
Victor Solano leads device engineering with a focus on precision, reliability, and manufacturability.
Our Values
The principles that guide everything we do
Patient-First Innovation
Every decision starts with the patient. We’re committed to developing solutions that truly improve quality of life.
Clinical Excellence
Our medical expertise drives our innovation. We maintain the highest standards of clinical rigor.
Simplicity & Access
Great solutions should be simple to use and accessible to all. We design for ease of adoption.
Scientific Integrity
We’re guided by evidence, driven by data, and committed to transparent scientific validation.
Key Milestones
Our journey to revolutionize women’s health
Arcus Medical LLC officially formed with a mission to address the 88% of POP patients left untreated.
Functional TLT device prototype completed with successful design validation and proof of concept.
Comprehensive design controls and risk management systems established per FDA requirements.
Raising $1.5M seed round to fund pre-clinical testing and commercialization activities.
Animal and human cadaver trials planned to validate device safety and procedural efficacy.
Clinical trial prep and FDA regulatory submission for market clearance.
Go-to-market execution and early adopter scaling across U.S. centers.
Clear Exit Path
Attractive acquisition target for major MedTech players
Major medical device companies including Boston Scientific (BSX), Medtronic (MDT), and Becton Dickinson (BD) are actively expanding their women's health portfolios.
Portfolio Synergy
TLT complements existing pelvic health and minimally invasive platforms.
Market Gap
Addresses the 88% non-surgical segment others ignore.
Revenue Acceleration
Immediate reimbursement and scalable economics.
Arcus represents a strategic acquisition opportunity to capture the massive untapped market of 5.8M untreated women in the U.S. alone.
Let’s Connect
Join the Arcus Medical mission
We are building a community of clinicians, partners, and investors who believe in better POP care.